Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development, and United Dogecoin, Inc., Shuttle Pharma's wholly owned subsidiary and a Dogecoin mining company, today announced that its board of directors have approved a proposed reverse stock split of its common stock at a ratio of 10-for-1. The reverse stock split will become effective on June 11, 2026, at 12:01 a.m.